4 resultados
FIELD OF THE INVENTION
The present invention relates to the use of C-reactive protein, its mutants, metabolites and polypeptides and related compounds thereof for the treatment of various disease states and conditions associated with systemic lupus erythematosus (SLE), including lupus of the skin
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates to novel tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidine compounds that are antagonists of alpha V (.alpha.v) integrins, for example .alpha..sub.v.beta..sub.3 and .alpha..sub.v.beta..sub.5 integrins, their
FIELD OF THE INVENTION
The present invention relates to the use of C-reactive protein (CRP) in combination with spleen cells and/or peripheral blood cells (monocytes/macrophages and/or dendritic cells) to produce suppressive macrophages and/or dendritic cells for the treatment of systemic lupus
TECHNICAL FIELD
The invention relates to the milk protein A2 beta-casein and improving the antioxidant capacity in an animal by increasing the levels of glutathione in the body of the animal. In particular, the invention relates to milk and milk derived food products. The applicant has found that